Fenagesic

Fenagesic

mefenamic acid

Manufacturer:

Sunward

Distributor:

Antah Pharma
Concise Prescribing Info
Contents
Mefenamic acid
Indications/Uses
Primary dysmenorrhea & relief of moderate pain when therapy will not exceed 1 wk.
Dosage/Direction for Use
Acute pain Adult & childn >14 yr 500 mg tds, usually not to exceed 1 wk. Primary dysmenorrhoea 500 mg tds, starting w/ onset of bleeding & associated symptoms. Dose regimen should not exceed >7 days at a time.
Administration
Should be taken with food: Take immediately after meals.
Contraindications
Hypersensitivity. Bronchospasm, allergic rhinitis or urticaria; active ulceration or upper/lower GIT chronic inflammation. Preexisting renal disease, renal impairment. Pregnancy & lactation.
Special Precautions
CV disease or risk, HTN, fluid retention or heart failure, severe skin reactions. History of GI events & risk factors associated w/ peptic ulcer disease (eg, alcoholism, smoking & corticosteroid therapy. Impaired renal function or history of kidney or liver disease. Childn <14 yr.
Adverse Reactions
GI upsets or rashes; haemolytic anaemia, agranulocytosis, pancytopenia, thrombocytopenia, thrombocytopenic purpura & bone marrow aplasia; diarrhea.
Drug Interactions
Monitor prothrombin time w/ oral anticoagulant. Reduced excretion of lithium.
ATC Classification
M01AG01 - mefenamic acid ; Belongs to the class of non-steroidal antiinflammatory and antirheumatic products, fenamates.
Presentation/Packing
Form
Fenagesic tab 500 mg
Packing/Price
10 × 10's
Form
Fenagesic oral susp 125 mg/5 mL
Packing/Price
100 mL x 1's;120 mL x 1's;60 mL x 1's
Form
Fenagesic cap 250 mg
Packing/Price
10 × 10's
Form
Fenagesic tab 250 mg
Packing/Price
10 × 10's
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in